The global urology laser market size was valued at USD 1.2 billion in 2025 and is projected to grow from USD 1.27 billion in 2026 to USD 2.03 billion by 2034, registering a CAGR of 6% during the forecast period from 2026 to 2034. North America dominated the urology laser market with a market share of 38.5% in 2025.
Urology lasers are medical laser systems used to diagnose and treat conditions affecting the urinary tract and male reproductive system. They are commonly used for kidney stone removal, prostate procedures, tumor treatment, and other minimally invasive surgeries. These systems offer precise tissue treatment with reduced bleeding and faster recovery. Demand is growing due to rising urological disorders, an aging population, and advances in laser-based surgical techniques.
Download a Free Sample To learn more about this report,
Growing Adoption of Minimally Invasive Laser Procedures
Urology laser market trends are being driven by the increasing use of minimally invasive laser procedures for kidney stones, benign prostatic hyperplasia (BPH), and other urological conditions. Holmium and thulium laser systems allow urologists to perform precise tissue treatment and stone fragmentation while reducing damage to surrounding tissues. Procedures such as laser lithotripsy and laser enucleation are gaining attention because they can support shorter hospital stays and faster patient recovery compared with more invasive approaches. These developments are supporting urology laser market growth as healthcare facilities invest in advanced technologies for efficient urological treatment.
Rising Adoption of Thulium Fiber Laser Technology
Thulium fiber lasers are gaining attention in urology because they provide precise energy delivery and flexible settings for stone fragmentation and soft-tissue procedures. Healthcare providers are increasingly evaluating these systems for applications such as kidney stone treatment and prostate surgery. Improvements in laser generators, fibers, and energy control are also helping surgeons perform procedures with greater precision and efficiency. Manufacturers are developing compact systems that can be integrated more easily into modern operating rooms. These advancements are strengthening urology laser market share by expanding the range of laser-based treatment options available to urologists.
Growing Prevalence of Kidney Stones and Urological Disorders
The urology laser market is growing steadily as hospitals and specialty clinics increasingly use laser systems to treat kidney stones, benign prostatic hyperplasia, urinary tract conditions, and other urological disorders. Laser procedures can provide precise tissue treatment with less bleeding and shorter recovery periods than many conventional surgical approaches. Rising patient preference for minimally invasive procedures and improvements in urological care are strengthening urology laser market demand globally.
For instance, in February 2025, hospitals expanded the use of advanced holmium and thulium laser systems for kidney stone fragmentation and prostate procedures to improve treatment precision and patient recovery.
High Equipment and Maintenance Costs
The urology laser market faces restraints because advanced laser systems require considerable upfront investment along with expenses for fibers, accessories, servicing, and staff training. Smaller hospitals and clinics may find these costs difficult to manage, particularly in regions with limited healthcare budgets. Specialized training is also necessary to operate laser equipment safely and effectively.
For instance, during April 2025, medical device providers increased flexible purchasing and equipment service programs for urology laser systems to help healthcare facilities manage installation and maintenance expenses.
Increasing Adoption of Thulium Fiber Laser Technology
The urology laser market offers strong opportunities as thulium fiber lasers and other advanced technologies gain attention for stone treatment and soft-tissue procedures. Improvements in energy control, fiber design, portability, and treatment precision can support more efficient minimally invasive procedures. Expanding urology infrastructure in emerging economies is also expected to strengthen urology laser market share over the coming years.
For instance, in July 2025, medical technology companies expanded thulium fiber laser platforms for urological applications to provide improved stone fragmentation capabilities and greater procedural flexibility for healthcare professionals.
Ensuring Clinical Safety and Consistent Treatment Outcomes
The urology laser market continues to face challenges in maintaining safe and consistent performance across different procedures and patient conditions. Incorrect laser settings can increase the risk of tissue injury, while differences in surgeon experience may influence treatment outcomes. Manufacturers must improve system controls, training programs, and safety features while meeting strict medical device regulations.
For instance, by October 2025, urology laser manufacturers increased the integration of automated energy controls and enhanced safety features to improve procedural consistency and support safer laser-based treatment of urinary conditions.
Holmium Laser System Segment Dominated the Market with 43.6% Share in 2025
The holmium laser system segment dominated the global urology laser market with a 43.6% share in 2025. Holmium lasers are widely used in urological procedures because of their effectiveness in stone fragmentation and treatment of enlarged prostate tissue. Their versatility across different minimally invasive procedures and established clinical use continue to strengthen the segment's leading position.
Thulium laser systems accounted for 25.4% and are growing at the highest CAGR of 8.2%, supported by their precise tissue cutting, controlled penetration, and increasing use in prostate procedures. Diode laser systems also remain important for various soft-tissue applications. Technological improvements in minimally invasive procedures are supporting urology laser market growth across different laser types.
Request Customizationto receive a tailored report.
Benign Prostatic Hyperplasia Segment Dominated the Market with 39.7% Share in 2025
The benign prostatic hyperplasia segment dominated the global urology laser market with a 39.7% share in 2025. Laser procedures are increasingly used to remove or reduce excess prostate tissue and improve urinary symptoms associated with an enlarged prostate. Growing preference for minimally invasive procedures with reduced bleeding and shorter recovery periods continues to support this segment.
Urolithiasis accounted for 36.5% of the market, driven by the extensive use of lasers for fragmenting kidney and urinary tract stones. Non-muscle-invasive bladder cancer is growing at a CAGR of 7.1%, supported by increasing adoption of advanced laser techniques in selected procedures.
Other applications contribute through specialized urological treatments. Increasing adoption of laser-based procedures is supporting urology laser market demand across different applications.
Hospitals & Clinics Segment Dominated the Market with 58.4% Share in 2025
The hospitals & clinics segment dominated the global urology laser market with a 58.4% share in 2025. These healthcare facilities perform a large number of urological procedures and have access to specialized surgeons, advanced laser systems, diagnostic equipment, and supporting infrastructure. Their ability to manage both routine and complex procedures continues to strengthen the segment's leading position.
Ambulatory surgical centres accounted for 25.3% and are growing at the highest CAGR of 8.1%. Increasing preference for outpatient procedures, shorter hospital stays, and minimally invasive treatments is supporting their expansion.
Dialysis centers and other healthcare facilities also contribute to demand for specialized urological treatments. The continued shift toward efficient outpatient care is expected to increase the adoption of laser-based procedures across different healthcare settings.
Speak to an Analystto discuss market opportunities.
North America urology laser market accounted for 38.5% of the global market, reaching USD 0.46 billion in 2025, and is projected to grow at a CAGR of 6.4% during the forecast period. The region benefits from advanced healthcare infrastructure, widespread adoption of minimally invasive urological procedures, and increasing treatment of kidney stones and benign prostatic hyperplasia. Hospitals and specialty clinics are also adopting advanced holmium and thulium laser systems to improve surgical precision and patient recovery.
The US market was valued at USD 0.39 billion in 2025, making it the largest contributor in North America. High adoption of minimally invasive urological procedures, advanced hospital infrastructure, and increasing use of laser systems for kidney stone and prostate treatments continue to support market growth.
Canada's market reached USD 0.07 billion in 2025. Growing adoption of minimally invasive treatments, improvements in urological care, and increasing availability of advanced laser technologies are supporting market development.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe urology laser market accounted for 28.2% of the global market, reaching USD 0.34 billion in 2025, and is expected to register a CAGR of 6.1% during the forecast period. An aging population, increasing prevalence of urological disorders, and growing preference for minimally invasive procedures are supporting regional demand. Hospitals are increasingly investing in advanced laser technologies that can reduce bleeding, shorten hospital stays, and improve treatment outcomes.
Germany's market accounted for USD 0.10 billion in 2025. Advanced healthcare infrastructure, strong adoption of minimally invasive surgery, and increasing availability of modern urology laser systems continue to support market growth.
The UK market was valued at USD 0.07 billion in 2025. Increasing treatment of kidney stones and prostate conditions, growing adoption of laser-based procedures, and improvements in urological healthcare services continue to contribute to market development.
Asia Pacific urology laser market accounted for 23.4% of the global market, valued at USD 0.28 billion in 2025, and is projected to register the fastest regional CAGR of 8.3% during the forecast period. Increasing healthcare expenditure, expansion of hospital infrastructure, and growing awareness of minimally invasive urological treatments are driving regional demand. Rising cases of kidney stones and prostate disorders are also increasing the need for advanced laser-based treatment systems.
Japan's market generated USD 0.05 billion in 2025. An aging population, advanced healthcare infrastructure, and strong adoption of minimally invasive medical technologies continue to support demand for urology laser systems.
China's market accounted for USD 0.15 billion in 2025, making it a major contributor within Asia Pacific. Expansion of hospital infrastructure, increasing healthcare expenditure, and growing adoption of advanced laser procedures for kidney stones and prostate disorders continue to drive market growth.
Middle East & Africa urology laser market accounted for 4.2% of the global market, reaching USD 0.05 billion in 2025, and is anticipated to grow at a CAGR of 6.6% during the forecast period. Investment in modern healthcare facilities, increasing access to specialized urological care, and growing adoption of minimally invasive procedures are supporting regional market development.
The UAE market was valued at USD 0.02 billion in 2025. Advanced hospital infrastructure, increasing investment in specialized medical technologies, and growing availability of minimally invasive urological procedures continue to support market growth.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Bioabsorbable Stents Market Size, Share, Growth, Analysis, 2034
Vessel Sealing Devices Market Size, Share, Growth, Analysis, 2034
ECG Patch and Holter Monitor Market Size, Share, Growth, 2034
Alpha Emitter Market Size, Share, Growth, Analysis, Report, 2034
Temperature Management Market Size, Share, Growth, Analysis, 2034
Surgical Stapler Market Size, Share, Growth, Forecast, 2034
We are featured on:
sales@straitsresearch.com